ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980

Centers Eligible For Comprehensive Identification Names; Rauscher To Pick Four Now, Two More Later

May 24, 1974

Committee Approves Concepts For Studies In Special Populations

December 11, 1987

NCI Evaluating PDQ Evaluation

September 1, 1989

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014